The expression of MAOA has been discovered to be high in prostate cancer and its overexpression in prostate oncocyte perineural aggression via SEMA3C/PlexinA2/NRP1-cMET signal transmission [27]. The gene discussed is MAOA; the disease is prostate carcinoma.